The Top Line

July 8, 2022


Listen Later

FDA officials want to reform the agency's accelerated approvals program, but Paul Hastings, chair of one of biotech's leading trade organizations, has some thoughts. Reforms could limit innovation, Hastings argues, but data suggest the program could be improved. We'll discuss the tug and pull between regulators and businesses.

But that's not all. A Vertex Pharmaceuticals’ diabetes  therapy is back on track. Two months ago the FDA placed a clinical hold on the drug, but now a trial is underway. And Orchestra BioMed has had a busy week with a SPAC deal and a Medtronic partnership. We'll cover that, plus this week's headlines. 

To learn more about the topics in this episode: 

  • Orchestra BioMed cues up Medtronic partnership, $400M SPAC deal
  • Vertex's Type 1 diabetes cell therapy heads back to clinic after FDA hold lifted
  • Dyne another day: DMD therapy back on track after FDA lifts clinical hold
  • Gun-shy on accelerated approvals, FDA will convene a 2nd expert panel meeting to reconsider Amylyx’s ALS candidate
  • Biogen-Eisai go for another biomarker approval in Alzheimer's with lecanemab—and snag priority review
  • The Top Line is produced by senior multimedia producer Teresa Carey with editor-in-chief Tracy Staton, managing editor Querida Anderson and senior editors Annalee Armstrong, Ben Adams, Conor Hale and Eric Sagonowsky. The sound engineer is Caleb Hodgson. The stories are by all our “Fierce” journalists. Like and subscribe wherever you listen to your podcasts.

    See omnystudio.com/listener for privacy information.

    ...more
    View all episodesView all episodes
    Download on the App Store

    The Top LineBy Fierce Life Sciences

    • 3.8
    • 3.8
    • 3.8
    • 3.8
    • 3.8

    3.8

    8 ratings


    More shows like The Top Line

    View all
    WSJ Your Money Briefing by The Wall Street Journal

    WSJ Your Money Briefing

    1,753 Listeners

    The McKinsey Podcast by McKinsey & Company

    The McKinsey Podcast

    381 Listeners

    a16z Podcast by Andreessen Horowitz

    a16z Podcast

    1,034 Listeners

    Exchanges by Goldman Sachs

    Exchanges

    991 Listeners

    Odd Lots by Bloomberg

    Odd Lots

    1,789 Listeners

    Macro Musings with David Beckworth by Mercatus Center at George Mason University

    Macro Musings with David Beckworth

    375 Listeners

    The Long Run with Luke Timmerman by Timmerman Report

    The Long Run with Luke Timmerman

    122 Listeners

    The Readout Loud by STAT

    The Readout Loud

    318 Listeners

    Inside the Strategy Room by McKinsey & Company

    Inside the Strategy Room

    171 Listeners

    Why It Matters by Council on Foreign Relations

    Why It Matters

    876 Listeners

    Business Of Biotech by Ben Comer

    Business Of Biotech

    88 Listeners

    BioCentury This Week by BioCentury

    BioCentury This Week

    29 Listeners

    Raising Health by Andreessen Horowitz, a16z Bio + Health

    Raising Health

    147 Listeners

    Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

    Biotech Hangout

    10 Listeners

    Ground Truths by Eric Topol

    Ground Truths

    51 Listeners